Discover our latest updates
Join our newsletter
Dec 7, 2022
MediSieve Announces Positive Final Results from Phase 1 Clinical Trial
Magnetic Blood Filtration Platform shown to be safe and well tolerated, with no serious adverse events.
May 24, 2022
MediSieve Announces First Volunteer Successfully Enrolled in Phase 1 Clinical Study
Radboud University Medical Center is Conducting Safety Evaluation of MediSieve’s System for the Treatment of Acute Hyperinflammation.
MediSieve Receives Approval for First-in-Man Clinical Investigation
Radboud University Medical Center will perform the first trial of the Novel Magnetic Haemoflitration System.
Feb 2, 2022
First Clinical Trials to Start at Radboud Medical Centre
Award winning company MediSieve is set to start their first-in-man clinical trials in the first quarter of 2022.
Feb 15, 2021
MediSieve Expands Their Lab Space
The expansion enabled MediSieve to have full control over safety and equipment to meet the company's R&D needs
Apr 29, 2020
MediSieve Expands its Research Into Treating COVID-19
The team focused its activities on investigating how to help treat COVID-19 patients more effectively.
Apr 3, 2020
The current pandemic is a stark reminder to us all of the importance of our work and its potential impact.
May 8, 2018
MediSieve to take blood filtration research into fight against leukaemia
MediSieve, the company behind a revolutionary magnetic sieve that filters out malaria-infected cells directly from a patient’s bloodstream, is developing new methods to fight leukaemia.
Get in touch
Sign up to our newsletter
The future is magnetic